LAKEWOOD, Colo.--(BUSINESS WIRE)--Renal Ventures Management (RVM), a leading provider of dialysis services for patients suffering from chronic kidney disease, has recently opened the Renal Center of Englewood, LLC in Englewood, New Jersey. The center, which serves peritoneal dialysis (PD) patients managing their care at home, is the first stand-alone PD-only center in the state.
Advances in dialysis technology have brought about a renewed focus on PD as an effective, less costly and more convenient option for patients living with end-stage renal disease. Instead of spending several hours at least three times per week in a clinic for hemodialysis, patients on PD can choose to dialyze for less time daily around their own schedule or even while they sleep. This flexibility enables patients to work and enjoy life with fewer restrictions and typically more energy.
“Patients who come through our doors can expect individual attention from staff that is highly trained who help them navigate the specific needs of living on peritoneal dialysis,” said Louis Jan, M.D., medical director for the Renal Center of Englewood. “We are here to help guide and educate our patients to be experts in how to manage their own care. We take great pride in supporting them at every step in the process.”
A grand opening for the clinic will be held Wednesday, April 9, 2014, from 5:00 p.m. to 7:00 p.m. at 300 Grand Avenue, Suite 101, in Englewood. Staff will be giving tours of the clinic and of Bergen Kidney Center’s new offices, located next door. Bergen Kidney Center is a nephrology practice that specializes in treating a range of kidney related diseases and manages end-stage renal patients on dialysis. Staff from both centers, patients and local elected officials will be on-hand for the grand opening.
Peritoneal dialysis continues to be a growing area of end-stage renal care. Patients on PD are often healthier than their peers on hemodialysis. A 2009 study published in the American Journal of Managed Care found that patients on hemodialysis were twice as likely as patients on peritoneal dialysis to be hospitalized with complications from dialysis during a 12-month period. The study also found the cost of PD is significantly less than hemodialysis. On average, PD costs about $40,000 less per year than hemodialysis. With the added convenience of dialyzing at home or work, PD is one of the fastest growing treatment and research areas in the field of nephrology.
Renal Ventures Management is one of the industry leaders in offering PD care. The company’s medical advisory board continues to research and advance treatment protocols for PD patients. In addition to the Renal Center of Englewood, LLC, Renal Ventures operates Home Kidney Care, LLC in North Dallas, which also specializes in home dialysis management.
About Renal Ventures Management LLC
Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations which center around collaboration, quality and effectiveness. Headquartered in Lakewood, Colo., the company operates 36 dialysis partnerships and 25 inpatient service contracts in six states. They also operate seven infusion centers in two states treating patients with various autoimmune disorders. For more information, visit www.renalventures.com.
